Regeneron Pharma begins human trials of Covid-19 antibody ‘cocktail’
Team Udayavani, Jun 13, 2020, 10:03 AM IST
US-based Regeneron Pharmaceuticals has begun human trials of its antibody ‘cocktail’ as a treatment for Covid-19
The antibody which is called REGN-COV2, contains an antibody made by Regeneron and a second isolated from humans who recovered from Covid-19.
George Yancopoulos .Chief Scientific Officer, said“If it goes perfectly well, within a week or two we will move to the second phase. Within a month or so of that we will have clear data that this is or isn’t working. By the end of summer, we could have sufficient data for broad utilization”
Regeneron said its treatment could be useful even if a Covid-19 vaccine is developed since the elderly and people with compromised immune systems often do not respond well to vaccines.
The firm also plans to study REGN-COV2 for preventing the infection in people at high risk of exposure.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
China trying to undermine Tibet’s identity, want to make world aware about it: Tibetan girl who was jailed for protesting
Don’t blame Dubai’s freak rain on cloud seeding
What role does genetics play in breast cancer? How can genetic testing help with early breast cancer diagnosis?
From Orbit to Earth: ISRO’s Contributions to Understanding Himalayan Glacial Shifts
Modi Supports Philippines with BrahMos Missiles in China Sea Dispute
MUST WATCH
Latest Additions
Congress accuses Modi Government of undermining reservations through privatization
IPL 2024: Jacks, Kohli power RCB to easy win over GT
3 injured as speeding Jaguar hits vehicles in Delhi, accused on run
HC grants murder convict parole for 2 weeks to get married
Pakistan’s Foreign Minister Ishaq Dar appointed as deputy prime minister